Historical record - last NADAC publication: 2/19/2020

Product Information

PIOGLITAZONE-METFORMIN 15-500 is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.7737 per EA under NDC 57237021781. Its NADAC has been published 134 times since Aug 9, 2017.

PIOGLITAZONE-METFORMIN 15-500

Pioglitazone Hydrochloride and Metformin Hydrochloride
$0.7737per EA

Strength

500; 15 mg/1; mg/1

NDC

57237021781

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

2/19/2020

Approval Type

Generic (ANDA)

FDA Application

ANDA200823

On Market Since

2/13/2013

Pharmacological Classes

Biguanide
Biguanides
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE-METFORMIN 15-500 has been published 134 times since Aug 9, 2017, and over the history we have for it it has declined 26.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7737 per EA
All-time high$1.2349 (Feb 14, 2018)
All-time low$0.7538 (Oct 17, 2018)
Median price$0.9414
Average price$0.9428
Largest weekly change+43.5% (Jan 22, 2020)
Weeks tracked134
Tracking sinceAug 9, 2017

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-26.2%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE-METFORMIN 15-500?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-METFORMIN 15-500, manufactured by Rising Pharma Holdings Inc., is $0.7737 per EA (NDC 57237021781), effective Feb 26, 2020.

How has the price of PIOGLITAZONE-METFORMIN 15-500 changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE-METFORMIN 15-500 has declined 26.2%. It has been tracked across 134 weekly CMS publications since Aug 9, 2017.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-METFORMIN 15-500?

Since Aug 9, 2017, the NADAC for PIOGLITAZONE-METFORMIN 15-500 has ranged from a low of $0.7538 (Oct 17, 2018) to a high of $1.2349 (Feb 14, 2018), with a median of $0.9414 per EA.

Are there cheaper alternatives to PIOGLITAZONE-METFORMIN 15-500?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PIOGLITAZONE-METFORMIN 15-500, is $0.4108 per EA — about 47% below PIOGLITAZONE-METFORMIN 15-500.

Who manufactures PIOGLITAZONE-METFORMIN 15-500?

PIOGLITAZONE-METFORMIN 15-500 (NDC 57237021781) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.